Início › Glioma › Pensilvânia › Philadelphia
Ensaios clínicos de Glioma em Philadelphia, PA
16 estudos para Glioma estão buscando participantes em locais em Philadelphia e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RecrutandoFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · a 25 mi de distância
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecrutandoFase 2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecrutandoFase 1/2
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
RecrutandoFase 1 inicial
- The Children s Hospital of Philadelphia, Philadelphia
Targeted Pediatric High-Grade Glioma Therapy
RecrutandoEstudo observacional
- Children's Hospital of Philadelphia, Philadelphia
Study of Olutasidenib and Temozolomide in HGG
RecrutandoFase 2
- Children's Hospital of Philadelphia, Philadelphia
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecrutandoFase 3
- Thomas Jefferson University Hospital, Philadelphia
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecrutandoFase 2
- Children's Hospital of Philadelphia, Philadelphia
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
RecrutandoFase 1
- Children's Hospital of Philadelphia, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecrutandoFase 2
- Thomas Jefferson University, Philadelphia
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RecrutandoFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecrutandoFase 1 inicialVoluntários saudáveis bem-vindos
- Children's Hospital of Philadelphia, Philadelphia
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecrutandoFase 2
- Children's Hospital of Philadelphia, Philadelphia
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RecrutandoFase 1 inicial
- Children's Hospital of Philadelphia, Philadelphia
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
RecrutandoFase 2
- University of Pennsylvania, Philadelphia
18F-Fluciclovine PET-MRI in High-grade Glioma
RecrutandoFase 1 inicial
- Children's Hospital of Philadelphia, Philadelphia
Ensaios de Glioma em outras cidades
- New York City, NY25 estudos
- Houston, TX23 estudos
- Boston, MA20 estudos
- Washington, DC19 estudos
- Columbus, OH15 estudos
- Miami, FL15 estudos
- San Francisco, CA14 estudos
- Chicago, IL13 estudos
- Durham, NC12 estudos
- Seattle, WA11 estudos
- St. Louis, MO10 estudos
- Aurora, CO10 estudos
Outros estudos em Philadelphia
- Câncer (todos os tipos)59 estudos
- Câncer de Mama56 estudos
- Câncer de Pulmão de Não Pequenas Células51 estudos
- Câncer Metastático46 estudos
- Câncer de Próstata44 estudos
- Câncer Colorretal44 estudos
- Câncer de Ovário44 estudos
- Câncer de Pulmão36 estudos
- Leucemia Mieloide Aguda34 estudos
- Insuficiência Cardíaca31 estudos
- Câncer Endometrial28 estudos
- Depressão26 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.